August 6, 2019
Cardiovascular Systems, Inc. Reports Fiscal 2019 Fourth-Quarter Financial Results
Conference Call Scheduled for Today, August 6, 2019, at 3:30 PM CT (4:30 PM ET) Revenues of $68.2 million increased…
Pharmaceuticals, Biotechnology and Life Sciences
Conference Call Scheduled for Today, August 6, 2019, at 3:30 PM CT (4:30 PM ET) Revenues of $68.2 million increased…
BRISBANE, Calif.–(BUSINESS WIRE)–Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that CEO Sandy Macrae will present at…
IMVEXXY® Net Revenue $3.1 Million for the Second Quarter of 2019 Total Net Revenue for the Second Quarter of 2019…
– Fully-enrolled AURORA Phase 3 trial in lupus nephritis continues on track with results anticipated in late 2019 – –…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced…
Webcast and Conference Call today at 4:30 p.m. ET Royalty revenue for the quarter was $44.4 million Phase 2a NASH…
DUBLIN–(BUSINESS WIRE)–The “Oligonucleotide Synthesis Market by Product, Type (Custom, Pre design), Application (PCR, DNA, RNAi, Research, Therapeutic), End User –…
BEDFORD, Mass.–(BUSINESS WIRE)–#dravet–Stoke Therapeutics, Inc., (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of…
SAN FRANCISCO–(BUSINESS WIRE)–JMP Group LLC (NYSE: JMP), an investment banking and alternative asset management firm, announced today that Reni Benjamin,…
DUBLIN–(BUSINESS WIRE)–The “World Pharmaceutical Packaging Equipment Market – Opportunities and Forecasts, 2017 – 2023” report has been added to ResearchAndMarkets.com’s…